Optimizing insulin regimens in type 1 diabetes: How to help patients get control of their life

Postgraduate Medicine

Volumn 113, Issue 6, 2003, Pages

  Bohannon, Nancy J V ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; GLUCOSE; INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; INSULIN ZINC SUSPENSION; ISOPHANE INSULIN; LENTE; UNCLASSIFIED DRUG;

ALGORITHM; BLOOD GLUCOSE MONITORING; CARBOHYDRATE INTAKE; CONFERENCE PAPER; DIABETES CONTROL; EXERCISE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN TREATMENT; LIFESTYLE; PATHOPHYSIOLOGY; POSTPRANDIAL STATE; PRACTICE GUIDELINE; QUALITY OF LIFE;

EID: 0038810287     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2003.06.1430     Document Type: Conference Paper

References (7)

1. Barnett AH, Owens DR. Insulin analogues. Lancet 1997;349(9044):47-51
2. Lepore M, Pampanelli S, Fanelli C, et al. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro. Diabetes 2000;49(12):2142-8
3. White JR Jr, Campbell RK, Hirsch I. Insulin analogues: new agents for improving glycemic control. Postgrad Med 1997;101(2):58-70
4. Bergstrom RW, Wahl PW, Leonetti DL, et al. Association of fasting glucose levels with a delayed secretion of insulin after oral glucose in subjects with glucose intolerance. J Clin Endocrinol Metab 1990;71(6):1447-53
5. Gerich JE. Pathogenesis and treatment of type 2 (noninsulin-dependent) diabetes mellitus (NIDDM). Horm Metab Res 1996;28(9):404-12
6. Howey DC, Bowsher RR, Brunelle RL, et al. [Lys(B28), Pro(B29)]-human insulin: a rapidly absorbed analogue of human insulin. Diabetes 1994; 43(3):396-402
7. Pfeifer MA, Halter JB, Porte D Jr. Insulin secretion in diabetes mellitus. Am J Med 1981;70(3):579-88